Skip to main content

and
  1. No Access

    Article

    Re-thinking the perception of long-term opioid use in RMDs

    Emerging data suggest that the frequency of long-term opioid use is high among individuals with rheumatic and musculoskeletal diseases, which is of concern given the risks of opioid misuse. But is long-term op...

    Serge Perrot, Anne-Priscille Trouvin in Nature Reviews Rheumatology (2023)

  2. Article

    Open Access

    Expert Consensus on Clinical Use of an Orally Administered Dexketoprofen Plus Tramadol Fixed-Dose Combination in Moderate-To-Severe Acute Pain: A Delphi Study

    In 2016, the orally administered fixed-dose combination of dexketoprofen 25 mg and tramadol 75 mg (DKP/TRAM FDC) was approved in Europe for short-term treatment of moderate-to-severe acute pain, an indication ...

    Giustino Varrassi, Stefano Coaccioli, Josè De-Andrés, Magdi Hanna in Advances in Therapy (2019)

  3. Article

    Open Access

    Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus

    The clinical management of inflammatory pain requires an optimal balance between effective analgesia and associated safety risks. To date, mechanisms associated with inflammatory pain are not completely unders...

    Giustino Varrassi, Eli Alon, Michela Bagnasco, Luigi Lanata in Advances in Therapy (2019)

  4. No Access

    Article

    Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis

    The aim of the study is to evaluate the performance of extreme patient-reported outcomes (PRO) against definitions of fibromyalgia (FM) in patients with axial spondyloarthritis (axSpA).

    Daniela Santos-Faria, Maxime Dougados, Laure Gossec in Rheumatology International (2019)

  5. Article

    Open Access

    Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

    The long-term safety and therapeutic response of sodium oxybate (SXB) in fibromyalgia syndrome (FM) patients were assessed for a combined period of up to 1 year in a prospective, multicenter, open-label, exten...

    Michael Spaeth, Cayetano Alegre, Serge Perrot in Arthritis Research & Therapy (2013)

  6. Article

    Open Access

    Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains

    Patients with fibromyalgia (FM) report widespread pain, fatigue, and other functional limitations. This study aimed to provide an assessment of the burden of illness associated with FM in France and its associ...

    Serge Perrot, Caroline Schaefer, Tyler Knight in BMC Musculoskeletal Disorders (2012)

  7. Article

    Open Access

    Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: The DEFI study (Determination of Epidemiology of FIbromyalgia)

    Fibromyalgia is a common disease, but little is known on its real prevalence in France. This epidemiological study aimed to assess fibromyalgia (FM) prevalence in the French metropolitan population, based on a...

    Serge Perrot, Eric Vicaut, Dominique Servant in BMC Musculoskeletal Disorders (2011)

  8. Article

    Open Access

    Are joint and soft tissue injections painful? Results of a national French cross-sectional study of procedural pain in rheumatological practice

    Joint, spinal and soft tissue injections are commonly performed by rheumatologists in their daily practice. Contrary to other procedures, e.g. performed in pediatric care, little is known about the frequency, ...

    Serge Perrot, Françoise Laroche, Coralie Poncet in BMC Musculoskeletal Disorders (2010)